Erxia Qingxin Pian
Natural health product licensed in Canada
- Other names
- Chongcao Qushi Qingxin Pian, Chongcao Qushi Qingxin Tablet, Erxia Qingxin Tablet, UHerb Erxia Qingxin Tablet
- Licence holder
- Pharma Herb Inc.
- NPN or DIN-HM
- 80144296
- Status
- Active licence
- Licence date
- 22 September 2025
- Revision date
- 17 March 2026
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Pueraria montana var. lobata (Willd.) Sanjappa & Pradeep: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Pinellia ternata Source : Pinellia ternata - Rhizome Extract : Matériel brut sec Extraction ratio : 9.023:1 Dry plant equivalent : 120 mg | 13.3 mg | Not calculated |
| Glycyrrhiza glabra Extract : Matériel brut sec Extraction ratio : 8.955:1 Dry plant equivalent : 60 mg | 6.7 mg | Not calculated |
| Ophiocordyceps sinensis | 30 mg | Not calculated |
| Bambusa tuldoides Extract : Matériel brut sec Extraction ratio : 9.023:1 Dry plant equivalent : 120 mg | 13.3 mg | Not calculated |
| Citrus aurantium Source : Citrus aurantium - fruit Extract : Matériel brut sec Extraction ratio : 9.023:1 Dry plant equivalent : 120 mg | 13.3 mg | Not calculated |
| Citrus reticulata Extract : Matériel brut sec Extraction ratio : 9:1 Dry plant equivalent : 180 mg | 20 mg | Not calculated |
| Wolfiporia extensa | 100 mg | Not calculated |
| Acorus gramineus Extract : Matériel brut sec Extraction ratio : 9.023:1 Dry plant equivalent : 120 mg | 13.3 mg | Not calculated |
| Pueraria montana var. lobata Extract : Matériel brut sec Extraction ratio : 9:1 Dry plant equivalent : 180 mg | 20 mg | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extract : Matériel brut sec Extraction ratio : 8.929:1 Dry plant equivalent : 50 mg | 5.6 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Dextrine, Hypromellose, Sucre, Talc
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 3 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine. Traditional Chinese Medicine used to strenghten the spleen, remove phlegm and relieve restlessness. Traditional Chinese Medicine used for for symptoms of phlegm stagnation obstructing the interior.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80144296
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.